Related by context. All words. (Click for frequent words.) 73 kidney urologic 73 CYT# potent vascular disrupting 71 novel VDA molecule 71 BCG refractory carcinoma 70 AAG geldanamycin analog 69 Alfacell proprietary ribonuclease 69 pancreatic prostate 69 certain protein tyrosine 69 ovarian pancreatic 69 candidates Azedra TM 69 CYP#A# CYP#D# 69 protein tyrosine phosphatase 1B 69 bladder ovarian 69 oral picoplatin 69 K ras mutations 68 basal cell carcinoma squamous 68 mda 7 68 Telik logo TELINTRA 68 platform HDL Mimetic 68 pathophysiological effects 68 nilotinib Tasigna ® 68 5 HT2A serotonin 68 myelofibrosis polycythemia vera 68 HER2 HER2 68 DNA methyltransferase inhibitors 68 polysaccharide polymer 68 non porcine pancreatic 68 secretory phospholipase A2 68 novel emulsion formulation 68 PLX STROKE targeting 68 XL# anticancer compounds 68 accumulate preferentially 68 Vidaza ® 68 Papillary 68 GRNOPC1 contains 68 metastatic colorectal 68 Hsp# Inhibitor 68 mTOR mammalian target 68 CTAP# Capsules 67 oligodendrogliomas 67 resistant hormone refractory 67 ATRA IV 67 cell adhesion molecule 67 RAS RAF MEK 67 KRAS oncogene 67 orally administered inhibitor 67 hip osteonecrosis avascular 67 specific lectin receptors 67 Systemic lupus erythematosus SLE 67 factor HGF 67 Cardium Therapeutics TM 67 pancreatic lung 67 alpha folate receptor 67 Upregulation 67 aplastic anemia AA 67 triggers apoptosis programmed 67 adhesion molecule EpCAM expressing 67 NeoLipid R 67 metastatic pancreatic 67 papillary renal cell carcinoma 67 Janus kinase 67 Factor Receptor 67 aMCI precursor 67 cause cardiac channelopathies 67 poly ADP ribose polymerase 67 Protein Kinase C 67 syngeneic 67 HGS ETR1 mapatumumab 67 hypereosinophilic syndrome 67 proteomics bioinformatics 67 thromboxane A2 67 R sorafenib tablets 67 pancreatic endocrine 67 delivers fluocinolone acetonide FA 67 commercialize CorMedix drug 67 clinicopathological features 67 cisplatin resistant 67 Panzem R 67 lymphomas leukemias 66 coronary stent merged 66 Aurora Kinase 66 receiving chemoradiation therapy 66 EGFR pathway 66 DG# compounds targeting 66 Hepatocellular 66 FBPase 66 treating sarcoma testicular 66 Sudhir Agrawal D.Phil 66 intravesical infusion therapy 66 colorectal carcinoma 66 Ph + acute lymphoblastic 66 pancreatic colon 66 Cathepsin B 66 III EGFRvIII 66 Akt pathway associated 66 essential thrombocythemia ET 66 modified glutathione analog 66 Stromal 66 NS5b 66 Personalized Immunotherapy 66 TRAIL R1 66 chemoresistant 66 castration resistant hormone refractory 66 novel therapeutic antibodies 66 parathyroid carcinoma 66 ovarian endometrial 66 humanized therapeutic 66 dasatinib Sprycel 66 somatostatin analog 66 sapacitabine CYC# 66 fusion enhancers 66 LHRH receptor positive 66 GVAX ® 66 liver colon rectal 66 demonstrated antitumor activity 66 PDGFR B 66 receptor inhibiting monoclonal 66 refractory chronic lymphocytic 66 TRIOLEX HE# APOPTONE HE# 66 lymphangiogenesis 66 targeted radiotherapeutic 66 Antitumor Activity 66 deCODE ProstateCancer TM 66 epithelial tumors 66 peritoneal carcinomatosis 66 INSPIRE Trial Phase III 66 cyclin dependent kinases CDKs 66 Lymphocytic 66 gastrointestinal stromal 66 fibrotic disease 66 deCODE AF TM 66 MLL2 66 prostate carcinoma 65 treat musculoskeletal metabolic 65 leiomyoma 65 monoclonal antibody IgG1 Mab 65 pancreas esophagus 65 c myc gene 65 lung esophageal 65 RRM1 65 Clusterin 65 genetic substudy 65 ovarian breast 65 irinotecan doxorubicin oxaliplatin paclitaxel 65 androgen independent 65 IAP inhibitor 65 AGTR1 65 pralatrexate injection folate analogue 65 CYT# vascular disrupting 65 Surgical resection 65 ADVEXIN therapy 65 inflammatory PDE 65 NS5B polymerase 65 thrombin component 65 colorectal bladder 65 thymidylate synthase TS 65 chronic eosinophilic leukemia 65 Hypoxia Inducible Factor 65 Achieves Primary Endpoint 65 TIMP 1 65 carcinoembryonic antigen 65 Antigen Specific 65 peptidic compound 65 MAGE A3 ASCI 65 humanised monoclonal antibody 65 prednisone prednisolone plus 65 esophagus bladder 65 RNAi Therapeutic 65 LymphoStat B belimumab 65 Endometrial 65 pituitary adenomas 65 Diabetic macular edema 65 Ribavirin causes 65 antibody MT# 65 NASH Huntington 65 interferon alpha IFN 65 acetonide FA 65 induced mucositis 65 leukocyte adhesion 65 EGFR HER2 65 endometrial breast 65 4 PDE4 enzyme 65 novel antimitotic agent 65 histone deacetylase HDAC 65 underlying vasculopathy 65 ARRY # 65 cMET 65 ENMD # 65 MCSP respectively 65 FGFR3 65 dysplastic lesions caused 65 transthyretin TTR 65 ribonucleotide reductase clinically validated 65 MET VEGFR2 65 anthracycline induced 65 glutamic acid decarboxylase 65 5 FU leucovorin 65 LRP5 65 colorectal adenocarcinoma 65 eye socket ruptured 65 mutated p# 65 mutated K ras 65 alpha1 antitrypsin deficiency 65 #beta HSD1 65 antimitotic 64 included exfoliative dermatitis 64 HDL Selective Delipidation 64 HER1 64 leukemia multiple myeloma 64 Aeolus Pharmaceuticals Announces 64 rapamycin kinase 64 JAK2 Inhibitor 64 TELINTRA R 64 folate analogue metabolic 64 ENL recurrence 64 BRAF gene mutations 64 Empatic ™ 64 R Saizen R 64 myeloproliferative 64 retinoic acid receptor 64 RAS MAPK pathway 64 sarcoma melanoma 64 cyclin dependent kinase inhibitor 64 myelodysplastic myeloproliferative diseases 64 Aromatase 64 autosomal recessive disorder 64 malignant ovarian 64 Provectus Pharmaceuticals specializes 64 hyperphenylalaninemia HPA due 64 Solazed TM 64 exocrine 64 M2 subunit 64 p# Shc 64 FUSILEV enhances 64 FGFR2 64 deCODE BreastCancer 64 BRAF V#E 64 Xanafide 64 class mGluR5 inhibitor 64 R roscovitine 64 Tyrosine Kinase Inhibitor 64 neovasculature 64 androgen receptor AR 64 Philadelphia Chromosome Positive 64 VEGFR1 64 Systemic lupus erythematosus 64 Ag Cu Pb 64 cisplatin gemcitabine 64 ADAMTS# 64 ZFN TM 64 CDKN2A 64 Squamous cell 64 Prognostic factors 64 precursor lesions 64 HER2 overexpression 64 Sezary syndrome 64 dasatinib Sprycel ® 64 lung pancreatic 64 BRCA deficient 64 infection epistaxis dyspnea exfoliative 64 HER2 positivity 64 NKX#.# 64 metaglidasen 64 PNP inhibitor 64 PROSTVAC VF 64 Adenoviral 64 Fibrin MB 64 vascular occlusive diseases 64 stem cell pluripotency 64 aurora kinase 64 Angiotensin converting enzyme 64 RAF kinase VEGFR 64 MLH1 64 antiproliferative effects 64 metastatic neuroendocrine tumors 64 lintuzumab SGN 64 E#F# 64 estrogen receptor beta agonist 64 acid phosphatase PAP 64 MTHFR 64 Oral Fingolimod 64 Epidermal Growth Factor Receptor 64 neutropenia dehydration dyspnea 64 lead molecular radiotherapeutic 64 targets Galectin receptors 64 humanized interleukin 6 64 selective modulator 64 leiomyomas 64 Leukemias 64 dyslipidemia abnormal 64 pancreatic gastric 64 CAPE FEAR COMMUNITY COLLEGE 64 epithelial ovarian 64 inhibit vascular endothelial 64 Completes Patient Enrollment 64 Pancreatic insufficiency 64 VEGFR2 inhibitor 64 Kinase Inhibitor 64 myocardial infarction ventricular fibrillation 64 castrate resistant prostate cancer 64 Topoisomerase II 64 CYP#A# isoenzyme 64 cortisol synthesis 64 Mutational 64 Lenocta TM sodium stibogluconate 64 SSc 64 EGFR mutation positive 64 HER2 positive breast 64 PEGylated Fab fragment 64 molecule epidermal 64 renal fibrosis 64 CpG rich 64 Omacetaxine 64 uterine cervical 64 apoptosis proteins 64 Eg5 64 Small interfering RNAs 64 unresectable tumors 64 Randomized Phase II 64 xenograft models 64 HER signaling pathway 64 CEA CD# Her2 64 targeted anticancer biopharmaceuticals 64 related apoptosis inducing 64 SPRYCEL ® 64 Budesonide foam crofelemer 64 CCR9 64 Proc Am Soc 64 Human papillomavirus 64 C1 INH deficiency 64 introduced NEUGENE 64 vinca alkaloid 64 Interferon beta 64 TRAIL induced apoptosis 64 chronic progressive neurodegenerative 64 hyperplasia BPH 64 pharmacogenomic translational research 64 lymphoma multiple myeloma 64 descending thoracic 64 ERK1 2 64 Reports Preclinical Data 64 MET amplification 64 Cyclooxygenase 2 64 CYP#A# substrate 64 Crofelemer budesonide foam 63 refractory colorectal cancer 63 melanoma ovarian 63 IMiDs ® compound 63 M# rationally 63 GMX# 63 read Palintologist 63 GNAQ 63 JAK#/JAK# 63 proprietary polysaccharide 63 c MET 63 basal cell carcinoma BCC 63 Hutchinson Gilford progeria 63 oral dihydropyrimidine dehydrogenase DPD 63 MSCRAMM ® 63 Chronic pancreatitis 63 angiotensin analog 63 potent inducer 63 pain palliation 63 lysophosphatidic acid LPA 63 CDK cyclin dependent 63 treat chronic rhinosinusitis 63 Novel Oral 63 methyl CpG binding 63 novel proprietary KL4 63 clinicopathological 63 sunitinib Sutent 63 targeting miR 63 methylenetetrahydrofolate reductase 63 ABL inhibitor completing 63 selective inverse agonist 63 IgG1 monoclonal antibody 63 Myelofibrosis 63 TNF Tumor Necrosis Factor 63 histologic subtype 63 Shortened telomeres 63 RNAi therapeutic targeting 63 pleiotropic 63 AN# topical anti 63 bone marrow lymph nodes 63 p# biomarker 63 Acute myeloid leukemia 63 LRAT 63 manufactures minimally invasive 63 Cancer Incidence Mortality 63 pancreatic bladder 63 taxane derivative 63 chemokine receptor 63 pyrexia mucositis sepsis febrile 63 NPHP 63 severe malignant osteopetrosis 63 taxane chemotherapy administered 63 potent topoisomerase II 63 catheter occlusion 63 including KIT FLT3 63 novel synthetic PEGylated 63 cytidine nucleoside analog 63 Tracheitis 63 endosomal release 63 Oxidative damage 63 RhuDex R 63 tumors GIST 63 induces apoptosis 63 MKC# MKC# PP 63 tests miRview TM 63 Files IND 63 Presents Preclinical Data 63 cytolytic 63 Provacel TM 63 Factor VIIa 63 HER2 expression 63 Levels Linked 63 Heterozygous 63 Soluble CD# 63 MELAS 63 Initiates Enrollment 63 Combination REOLYSIN R 63 stage IIIb IV 63 Ep CAM 63 Cell Mol Physiol 63 antibody MAb 63 Leydig cell 63 CCR9 antagonist 63 eIF 4E 63 rib cage mangled 63 Flt3 63 Tß4 63 Preclinical Study 63 EGFr expressing metastatic colorectal 63 CFTR cystic fibrosis transmembrane 63 MTP inhibitor 63 agonistic human 63 evaluating picoplatin 63 tumorigenicity 63 Mg Uk 63 inhibit oxidative stress 63 boxer dachshund bulldog 63 Idiopathic pulmonary fibrosis IPF 63 By PETER LARSEN 63 DNA hypermethylation 63 Anthrax Toxin 63 pentadentate logo R 63 tongue mouth pharynx 63 About Positron Positron 63 JAK1 63 Seliciclib 63 sarcomatoid 63 metalloproteinase 63 Bucindolol Based 63 Raf MEK ERK 63 antiangiogenesis therapies 63 Vascular Disrupting Agent 63 next generation URAT1 63 castrate resistant 63 radiochemotherapy 63 investigational oral inhibitor 63 #.#/#GL# 63 selective serotonin 2C receptor 63 MKC# MT 63 Dystrophin 63 pancreatic islet cell 63 tyrosine kinase receptor 63 TTR gene 63 Oral Calcitonin 63 pan HDAC inhibitor 63 Endologix Powerlink System 63 breast ovary 63 #:#-# [020] 63 prostate cancer antigen prostatic 63 chronic granulomatous disease 63 TÎ ² 4 63 progressive neurodegenerative 63 novel topoisomerase 63 locoregional recurrence 63 neuropathic pain spasticity 63 liposomal formulation 63 endocrine therapies 63 dyskeratosis congenita 63 bFGF 63 Tay Sachs thalassemia 63 subependymal giant cell 63 HDAC enzymes 63 chronic myeloid 63 orthotopic model 63 Humanized Anti 63 sorafenib tablets 63 induced tumor regression 63 triciribine phosphate monohydrate 63 Smac mimetics 63 Septin9 biomarker 63 5 lipoxygenase 63 Colaris Colaris AP 63 Epstein Barr Virus EBV 63 AT1R 63 A3 adenosine receptor 63 protein tyrosine phosphatases 63 Ad5FGF 4 63 J Am Coll 63 mTOR kinase 63 Li Fraumeni 63 Archexin 63 2 methoxyestradiol 63 complement inhibitor eculizumab 63 thymidylate synthase 63 antiangiogenic activity 63 aberrantly activated 63 Xcytrin R 63 kinase PI3K Akt pathway 63 tumor angiogenesis inhibitors 63 ADPKD 63 intermediate filaments 63 telomerase reverse transcriptase 63 brand ciclesonide HFA 63 alpha GAL 63 targeting CD# 63 Alzheimer disease cognitive impairment 63 G#DT 63 used DNA alkylating 63 survival motor neuron 63 TLR7 agonist 63 % CI #.#-#.# [005] 63 LHRH antagonists 63 damage cirrhosis liver 63 PI3K/Akt pathway inhibitor 63 recurrent metastatic ovarian cancer 63 hypermethylated 63 mGluR2 NAM 63 world safest multivalent 63 nonmetastatic 63 oral prodrug 63 abnormal vascularization angiogenesis 63 Enterobacter spp 63 Inc. NASDAQ VSGN 63 Fas ligand 63 fluoropyrimidine 63 urinary bladder wall 63 gastric carcinoma 63 chronic idiopathic thrombocytopenic purpura 63 cardio metabolic diseases 63 Inhaled nitric oxide 63 ruffle hem black 63 HuCNS SC ® 63 Meets Primary Endpoint 63 nausea dehydration dyspnea 63 PTPN# 63 neuropathic pain metabolic diseases 63 developing Bicifadine serotonin 63 Bafetinib 63 Secretase 63 Receives Orphan Drug Designation 63 Pathway Inhibitor 63 IMiDs R 63 recurrent NSCLC 63 pretransplant 62 benign neoplasms 62 GSTP1 62 hypoxia inducible factor 62 TRAIL Receptor 62 myogenesis 62 potently inhibit 62 Parathyroid hormone 62 hormone receptor negative 62 left ventricular diastolic 62 gastric carcinomas 62 oral isoform selective HDAC 62 Epigenomics proprietary 62 COPEGUS therapy 62 MULLIGAN FAMILY FUN CENTER 62 hypoxia activated prodrug 62 personalized cellular immunotherapy 62 E CENP E 62 myopathies 62 surgically resected 62 AGS PSCA 62 hormone refractory prostate 62 Oracea TM 62 TNF blocker therapy 62 heparanase 62 KRAS mutant 62 VIPR2 62 Gleevec resistant 62 T#I [002] 62 anionic backbone 62 benign prostatic hyperplasia enlarged 62 Initiates Phase II 62 RhuDex ™ 62 chimeric monoclonal antibody 62 c MYC 62 PEGylated anti 62 CD# CEA 62 Cytotoxic T 62 PCA3 gene 62 secondary hyperparathyroidism 62 selective angiogenic kinase inhibitor 62 Menopausal hormone therapy 62 technology Parthenogenesis 62 ovarian lung 62 HCV NS5B polymerase 62 reversible inhibitors 62 HARD ENOUGH WITH 62 Emily Blunt shimmered 62 rxRNA 62 Ceres Jupiter 62 kidney allograft 62 #rd Annual CTRC 62 stent neointimal growth 62 hemorrhage necrosis 62 AAV vector carrying 62 STAT3 signaling 62 By Samantha Pidde 62 metabolomic profiles 62 Evoltra ® 62 Metastases 62 relapsed MM 62 dilated cardiomyopathy DCM 62 skeletal metastases 62 upregulates 62 metastatic GIST 62 thiopurine drugs 62 infectious diseases autoimmune diseases 62 monogenic 62 phosphate S1P 62 HER2 receptor 62 non polyposis colorectal 62 Oral NKTR 62 Emil Protalinski Published 62 molecular imaging radiopharmaceutical 62 progressive neurodegenerative disorder 62 ALN TTR 62 Eg5 kinesin spindle 62 Pharma Merck Serono 62 monocyte chemoattractant protein 62 IMiDs ® 62 recurrent glioblastoma multiforme 62 survivin expression 62 extracellular signal 62 Basal cell 62 immunodeficiencies 62 prostate cancer benign prostatic 62 Wnt signaling pathway 62 Introgen ADVEXIN 62 Vascugel 62 glucocerebroside primarily 62 HIF 1alpha 62 haematologic 62 acute myeloid 62 hematological cancers notably 62 MMP2 62 pro angiogenic 62 Atopic eczema 62 vapreotide acetate 62 c KIT 62 www.introgen.com 62 Atypical Hemolytic Uremic Syndrome 62 Carcinoid tumors 62 inherited neurodegenerative 62 thetreatment 62 Marcus Gronholm BP 62 adrenocortical cancer 62 treat chronic sinusitis 62 NMIBC 62 refractory metastatic 62 Initiates Clinical Trial 62 Zalypsis 62 mediated inhibition 62 Mg Usa 62 PI3K/mTOR 62 noninvasive outpatient 62 TSC1 62 dysplasias 62 polyneuropathy HIV DSP 62 Activating mutations 62 Exelixis XL# 62 tryptase 62 inhaled TPI ASM8 62 Acute lymphoblastic leukemia 62 trial evaluating PRX# 62 tendon dislocated shoulder 62 Rosetta Genomics Nasdaq ROSG 62 intracranial atherosclerosis 62 4SC AG ISIN DE# 62 TO AVOID PREGNANCY WHILE 62 Adjuvant chemotherapy 62 nonsense mutations 62 delta gamma agonist 62 neurodegenerative disorder characterized 62 1 diabetes T1D 62 palonosetron hydrochloride Injection Dacogen 62 Polycystic ovary syndrome PCOS 62 PDGFR 62 vascular disrupting agents 62 whose tumors overexpress 62 effector function 62 TOP2A 62 hepatocellular 62 polycythemia vera essential thrombocythemia 62 histone methyltransferase 62 carcinoma mCRC 62 product candidate Lpathomab 62 apolipoprotein E4 62 5 HT6 receptor 62 NSCLC tumors 62 potent suppressor 62 GATA3 62 Chronic HCV 62 hepatoma 62 collagen vascular 62 mTOR signaling pathway 62 Interferon gamma 62 selective kinase inhibitor 62 bladder prostate 62 metastatic gastric 62 Planetwide Media My 62 candidate alferminogene tadenovec 62 Bayer HealthCare Onyx Pharmaceuticals 62 osteoprotegerin 62 Fludara ® 62 STRATEGY FOR AN OPEN 62 Trastuzumab DM1 62 targets EpCAM expressing 62 oral isotype selective HDAC 62 VEGF receptor 62 engineered RAP peptides 62 USP Tablets PEPCID 62 murine leukemia 62 RNA antagonist 62 CysDisplay R 62 epithelial origin 62 Lyn kinase 62 trastuzumab Herceptin R 62 Virulizin ® 62 NATIONAL ECONOMIC COUNCIL DIRECTOR 62 ErbB2 positive 62 Pruvel ™ 62 Signaling Pathway 62 Lupus nephritis 62 E cadherin expression 62 Otelixizumab 62 Novel Inhibitor 62 telomere dysfunction 62 mineralocorticoid receptor 62 clonogenic 62 endometrial ovarian 62 Hereafter Inception Iron Man 62 Abstract Accepted 62 downregulates 62 ABCB1 62 Nevada Casino Aztar 62 tubulin inhibitor 62 metabolism viral replication 62 acetylcholinesterase AChE 62 non mutated KRAS 62 YOUR LOCAL ANIMAL SHELTER 62 RON Notch 62 protein tyrosine kinase 62 cause mesothelioma asbestosis 62 Pain Neutralizer holds 62 Pruvel TM 62 colorectal adenoma 62 Shows Promise Against 62 Tumor Response 62 siRNA conjugates 62 tensin homolog 62 C#Y 62 cervical breast 62 proteasome inhibitor 62 evaluate ZFP Therapeutic 62 regulator CFTR gene 62 active AKT inhibitor 62 5 HT4 62 muscular dystrophy cystic fibrosis 62 humanised antibody designed 62 AA Amyloidosis 62 topical antifungal product 62 Myelodysplastic syndromes MDS 62 NKG2D 62 tumor activated prodrug 62 Tumour Vascular Disrupting Agent 62 MGd 62 AML MDS 62 lung ovary 62 p# tumor suppressor 62 hereditary emphysema 62 Mitral valve repair 62 Extracellular Matrix 62 microprocessors microcontrollers digital 62 hematological parameters 62 Ostarine ™ 62 sunitinib Sutent ® 62 ornithine decarboxylase 62 MSH2 62 MediGene focuses 62 Skeletal muscle contractility 62 glial derived neurotrophic 62 fibrin derived 62 B Raf 62 forodesine purine nucleoside phosphorylase 62 Tutoplast Process R 62 includes Dideco CarboMedics 62 intercellular adhesion molecule 62 attach auristatin 62 Erythropoietic therapies may 62 Cystatin C 62 cervix colon 62 signal transduction inhibitors 62 XOMA 3AB biodefense 62 Terra Incognita Golden 62 situ hybridization ISH 62 CFTR gene 62 MDS MPD 62 Cardiorespiratory fitness 62 thyroid peroxidase 62 urothelial 62 metastatic lymph nodes 62 promoter hypermethylation 62 malignant pancreatic 62 abnormal glucose metabolism 62 chronic thromboembolic pulmonary 62 Perifosine KRX 62 Pulmonary arterial hypertension 62 gastrointestinal mucositis 62 Submits IND 62 Systemic Delivery 62 Sipuleucel T 62 metastatic renal 62 selective inhibition 62 gamma globin gene 62 anti CD3 62 nonhereditary 62 vWF 62 orally bioavailable mimics 62 normal karyotype 62 RONDEL ™ 62 CRTH2 62 reversible inhibitor 62 oral kinase inhibitor 62 Vertebral Fractures 62 JAK2 enzyme 62 Factor XIII 62 TP# gene 62 anti miRs antisense oligonucleotide 62 granzyme 62 histological subtype 62 Sangamo BioSciences Announces 62 activin receptor type 62 Von Willebrand disease 61 circulating endothelial cells 61 Aflibercept VEGF Trap 61 D aspartate NMDA receptor 61 breast carcinomas 61 Hsp# inhibition 61 #beta HSD 1 61 mutational status 61 oral Janus kinase 61 psoriatic arthritis PsA 61 Cardiotoxicity 61 induced angiogenesis 61 targeted diseased tissues 61 thoracoscopic lobectomy 61 Squalamine 61 Kit CD# positive 61 metastatic lesions involving 61 kinase inhibition 61 malignant prostate 61 #ME# 61 fine needle aspirate 61 peptibody 61 interleukin IL -# 61 factor TNF receptor 61 mitogen activated ERK kinase 61 cyclin dependent kinase CDK 61 TRIOLEX HE# 61 Surgical Hemostat proprietary 61 antiangiogenic agent 61 inactivating mutations 61 Talabostat 61 BCR ABL protein 61 2A receptor agonist 61 antagomirs 61 Prodarsan R 61 fibrin deposition 61 inducible nitric oxide synthase 61 fungal infections malaria tuberculosis 61 TMPRSS2 ERG 61 R rilonacept Injection 61 mucinous 61 NPC 1C 61 pluripotent human 61 ovarian colon 61 BRCA1 BRCA2 61 receptor tyrosine kinase inhibitor 61 Tumor Necrosis Factor 61 urate oxidase 61 INxin 61 Vaccine Adjuvant 61 B7 H3 61 Arch Surg 61 epilepsy Parkinson disease 61 advanced malignant hepatic 61 TGF alpha 61 carcinoma HCC 61 Diomed EVLT R 61 upregulating 61 Diabetic Foot Ulcer 61 XYOTAX TM 61 product platforms AZX# 61 including HGF ErbB3 61 metastatic ocular 61 Polymorphisms 61 COL#A# 61 rheumatoid arthritis systemic lupus 61 Guinness NF H 61 c Raf kinase 61 ERK pathway 61 Akt activation 61 relapsed acute myelogenous 61 small molecule Hedgehog 61 pancreatic adenocarcinoma 61 Relapsed Refractory 61 leukotriene pathway 61 dimebon latrepirdine 61 TMPRSS2 ERG fusion 61 CEQ# 61 By Dave Ornauer 61 products MKC# PP 61 myeloproliferative diseases 61 nonmelanoma 61 alpha#beta# integrin 61 Elizee suffered 61 Severe Sepsis 61 Enzastaurin 61 autosomal dominant disorder 61 potently inhibits 61 motor neuron degeneration 61 Pechanga Theater 61 BRCA2 carriers 61 endophenotypes 61 hemodynamically significant 61 myomas 61 cystic fibrosis chronic pancreatitis 61 Tumor necrosis factor 61 histologic findings 61 oral ghrelin agonist 61 Pegloticase 61 CIN lesions pre 61 recurrent metastatic 61 Tasigna prolongs 61 mGluR5 negative 61 chemo resistant 61 protein receptors lectins 61 Endometrial cancer 61 malignant ascites 61 mitogen activated protein kinases 61 negative allosteric modulator 61 non nucleoside inhibitor 61 SMN1 61 Immunotherapeutic 61 pulmonary metastases 61 familial amyloidotic polyneuropathy FAP 61 Emorys lived 61 mRNA encoding 61 uterine ovarian 61 topoisomerase II inhibitor 61 B lymphocyte stimulator 61 HLA DR4 immune 61 leukemia AML 61 Radical prostatectomy 61 TTR amyloidosis 61 AMRND 61 Anti Tumor 61 serine threonine 61 cervix uteri 61 Novel Therapeutic 61 Tesmilifene 61 multivariate Cox 61 Selective Inhibitor 61 Acute myelogenous leukemia 61 CCR5 delta# 61 HuMax TAC 61 PDX pralatrexate 61 inherited mutations 61 invasive lobular 61 HIF 1a 61 cyclin E 61 pathological hallmarks 61 ADAM# 61 psoriasis rheumatoid arthritis 61 osteogenic 61 Zorbtive TM 61 anti botulism antibody 61 beta islets 61 FLT3 61 CCX# 61 Quinamed R 61 Prednisone Against Refractory